Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Glaucoma-associated mutation of E50K-optineurin interferes autophagy-mediated degradation of TDP-43
Author Affiliations & Notes
  • Huiping Yuan
    Department of Ophthalmology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin,Heilongjiang, China
  • shiqi zhang
    Department of Ophthalmology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin,Heilongjiang, China
  • Zhengbo Shao
    Department of Ophthalmology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin,Heilongjiang, China
  • Footnotes
    Commercial Relationships   Huiping Yuan, None; shiqi zhang, None; Zhengbo Shao, None
  • Footnotes
    Support  National Nature Science Foundation of China (nos. 81470634)
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4338. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Huiping Yuan, shiqi zhang, Zhengbo Shao; Glaucoma-associated mutation of E50K-optineurin interferes autophagy-mediated degradation of TDP-43. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4338.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose :
E50K mutation of autophagy receptor gene Optineurin (OPTN) is known to be associated with normal tension glaucoma (NTG) and cause the damage of retinal ganglion cells (RGCs), but the pathogenesis mechanism remains unknown. Autophagy has been identified to be responsibility as the main pathway that promotes degradation of TAR DNA-binding protein 43 (TDP-43). In this study, we investigated the OPTN(E50K) mutation disrupting autophagy caused the aggregates of TDP-43 in vivo and their involvement in RGCs death.

Methods : OPTN(E50K) knock-in mice were generated by CRISPR/Cas9 in our laboratory and analyzed for genotype and phenotype. P62 and LC3-II expression in retina of wild type (WT) and OPTN(E50K) mice were measured by Western blotting, respectively. TDP-43 level was evaluated in cytoplasm from retinal tissues. Co-localization and distribution of optineurin and TDP-43 or LC3 were documented by co-Immunoprecipitation and Immunohistochemical analysis. Interaction between TARDBP and Dicer or Drosha was evaluated by the same way.

Results : Loss of RGCs (p<0.01) and decreased thickness of retina (p<0.05) were observed in OPTN(E50K) mice compared with WT mice. Also, we observed visual impairment (p<0.01) in OPTN(E50K) mice without increased IOP. Meanwhile, increased p62 and LC3-II level(p<0.05) in OPTN(E50K) mice indicated the inhibition of autophagy. A significantly increased amount of TDP-43 was observed in cytoplasm of retina from OPTN(E50K) mice compared to WT mice (p<0.05). Although both optineurin colocalized with TDP-43, assessment of the colocalization revealed that TDP-43-immunoreactive areas were more frequently colocalized with E50K optineurin in retinal cytoplasmic granules (p<0.01). Interestingly, TDP-43-positive granules contained less colocalized signals with both Dicer and Drosha in OPTN(E50K) mice(p<0.05).

Conclusions : Glaucoma-associated of E50K-optineurin mutation induced RGCs death and resulted in visual impairment in vivo. The autophagy disrupted by OPTN(E50K) affected the degradation of TDP-43 and may play an important role in E50K-mediated glaucomatous retinal degeneration.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×